J. Zhong

Application of Multi-Omics Approach in Sarcomas: A Tool for Studying Mechanism, Biomarkers, and Therapeutic Targets

Wanlin Liu, Yong Chen, Wei-li Sun, 2022, Frontiers in Oncology.

BRAF Inhibitor Resistance in Melanoma: Mechanisms and Alternative Therapeutic Strategies

Wangjun Yan, Chunmeng Wang, Yong Chen, 2022, Current Treatment Options in Oncology.

Comparative analysis of adjuvant therapy for stage III BRAF‐mut melanoma: A real‐world retrospective study from single center in China

Xin Liu, Wangjun Yan, Chunmeng Wang, 2023, Cancer Medicine.

CDCA2 promotes melanoma progression by inhibiting ubiquitin-mediated degradation of Aurora kinase A.

Wanlin Liu, Yong Chen, Wei-li Sun, 2023, European journal of cancer.

An advanced comprehensive muti-cell-type-specific model for predicting anti-PD-1 therapeutic effect in melanoma

Yong Chen, Yu Xu, Ming Ren, 2024, Theranostics.